Roundhill NVDA WeeklyPay ETF vs Revolution Medicines Inc. Common Stock — how do they compare? Roundhill NVDA WeeklyPay ETF trades at $37.13 (market cap $119.10M), while Revolution Medicines Inc. Common Stock trades at $189.4 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 338.5× Roundhill NVDA WeeklyPay ETF's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, Roundhill NVDA WeeklyPay ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Roundhill NVDA WeeklyPay ETF for 50 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| NVDW | RVMD | |
|---|---|---|
Market Cap | $119.10M | $40.32B |
Volume | 44,838 | 4,855,734 |
Sector | Income / Options Overlay | Health |
52-Week High | $52.33 | $221.15 |
52-Week Low | $31.88 | $47.50 |
Typical Hold Time | 50 Days | 0 Days |
Enterprise Value | — | $37.02B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
NVDW is an actively managed ETF that seeks to provide weekly distributions and returns equal to 1.2 times (120%) the calendar week performance of Nvidia (NVDA) common shares. It combines modest leverage with a high-frequency payout schedule, designed for investors who want amplified exposure to Nvidia alongside a consistent weekly income stream.
Read more on NVDW →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →